Cargando…
The Role of Rituximab in Primary Central Nervous System Lymphoma
PURPOSE OF REVIEW: The treatment of primary central nervous system lymphoma (PCNSL) is still under debate. One of the issues is the role of rituximab in improving the outcome. Here, we summarize the existing evidence, and comment on the literature on this topic. RECENT FINDINGS: Two randomized contr...
Autores principales: | Bromberg, Jacoline E. C., van der Meulen, Matthijs, Doorduijn, Jeanette K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324418/ https://www.ncbi.nlm.nih.gov/pubmed/32602069 http://dx.doi.org/10.1007/s11912-020-00941-8 |
Ejemplares similares
-
The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma
por: Van Dijck, Ruben, et al.
Publicado: (2021) -
Primary therapy and survival in patients over 70 years old with primary central nervous system lymphoma: a contemporary, nationwide, population-based study in the Netherlands
por: van der Meulen, Matthijs, et al.
Publicado: (2020) -
The Effects of Brain Tumours upon Medical Decision-Making Capacity
por: Hewins, Will, et al.
Publicado: (2019) -
Conditional relative survival in primary central nervous system lymphoma: a population-based study in the Netherlands
por: Dinmohamed, Avinash G, et al.
Publicado: (2020) -
MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma
por: van der Meulen, Matthijs, et al.
Publicado: (2021)